Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
Messahel B, Ashley S, Saran F, Ellison D, Ironside J, Phipps K, Cox T, Chong WK, Robinson K, Picton S, Pinkerton CR, Mallucci C, Macarthur D, Jaspan T, Michalski A, Grundy RG; Children's Cancer Leukaemia Group Brain Tumour Committee. Messahel B, et al. Among authors: cox t. Eur J Cancer. 2009 Jul;45(10):1815-23. doi: 10.1016/j.ejca.2009.03.018. Epub 2009 May 7. Eur J Cancer. 2009. PMID: 19427780
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG, Wilne SH, Robinson KJ, Ironside JW, Cox T, Chong WK, Michalski A, Campbell RH, Bailey CC, Thorp N, Pizer B, Punt J, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee. Grundy RG, et al. Among authors: cox t. Eur J Cancer. 2010 Jan;46(1):120-33. doi: 10.1016/j.ejca.2009.09.013. Eur J Cancer. 2010. PMID: 19818598 Clinical Trial.
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee. Grundy RG, et al. Among authors: cox t. Lancet Oncol. 2007 Aug;8(8):696-705. doi: 10.1016/S1470-2045(07)70208-5. Lancet Oncol. 2007. PMID: 17644039
Management and outcome of vein of Galen malformation.
McSweeney N, Brew S, Bhate S, Cox T, Roebuck DJ, Ganesan V. McSweeney N, et al. Among authors: cox t. Arch Dis Child. 2010 Nov;95(11):903-9. doi: 10.1136/adc.2009.177584. Epub 2010 Jul 6. Arch Dis Child. 2010. PMID: 20605862
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.
Carucci M, Clamp A, Zhou C, Hurt C, Glasspool R, Monaghan PJ, Thirkettle S, Wheatley M, Mahmood M, Narasimham M, Cox T, Morrison H, Campbell S, Nelson A, Holland-Hart D, Hopewell-Kelly N, Thomas A, Porter C, Slusarczyk M, Irving A, Dive C, Adams R, Jayson GC. Carucci M, et al. Among authors: cox t. BMC Cancer. 2024 Oct 24;24(1):1309. doi: 10.1186/s12885-024-13073-0. BMC Cancer. 2024. PMID: 39448911 Free PMC article.
1,467 results